Diabetes prevention: current promise and future directions

Affiliations

Comment

Mary Beth Weber. Lancet Diabetes Endocrinol. 2025 Jun.

. 2025 Jun;13(6):454-455.

doi: 10.1016/S2213-8587(25)00055-5. Epub 2025 Apr 28.

¹ Emory Global Diabetes Research Center, Emory University, Atlanta, GA 30030, USA. Electronic address: mbweber@emory.edu.

No abstract available

Conflict of interest statement

I have received financial travel support from the Novo Nordisk Foundation to attend the 2024 Global Diabetes Forum in Copenhagen, Denmark.

Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.
Knowler WC, Doherty L, Edelstein SL, Bennett PH, Dabelea D, Hoskin M, Kahn SE, Kalyani RR, Kim C, Pi-Sunyer FX, Raghavan S, Shah VO, Temprosa M, Venditti EM, Nathan DM; DPP/DPPOS Research Group. Knowler WC, et al. Lancet Diabetes Endocrinol. 2025 Jun;13(6):469-481. doi: 10.1016/S2213-8587(25)00022-1. Epub 2025 Apr 28. Lancet Diabetes Endocrinol. 2025. PMID: 40311647 Clinical Trial.